Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec:229:102722.
doi: 10.1016/j.autneu.2020.102722. Epub 2020 Sep 11.

Is there cardiac autonomic neuropathy in prediabetes?

Affiliations
Review

Is there cardiac autonomic neuropathy in prediabetes?

Lindsay A Zilliox et al. Auton Neurosci. 2020 Dec.

Abstract

Although there is considerably more data showing an association between type 2 diabetes mellitus (T2DM) and autonomic neuropathy, accumulating evidence indicates that cardiovascular autonomic neuropathy (CAN) is common in persons with impaired glucose tolerance (IGT). Furthermore, CAN may occur early after a metabolic insult and obesity, especially among mean, and seems to play an important role in the early pathogenesis of CAN. Autonomic symptoms are common in subjects with IGT. In addition to defects in CAN, in subjects with IGT, there is impaired sudomotor function and abnormalities of endothelial peripheral vasoreactivity. At the present time, the only interventions that may be effective in preventing or reversing IGT associated autonomic neuropathy are lifestyle improvement. These include a tailored diet and exercise program. Other approaches that may be beneficial include modulation of oxidative stress and improvement of metabolic regulation in subjects with IGT. Interventions are most likely to be effective early in the course of disease and therefore it is extremely important to have early diagnosis of IGT and autonomic neuropathy.

Keywords: Autonomic; Diabetes; Impaired glucose tolerance; Neuropathy.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Pattern of QSART abnormalities in subjects with IGT based on normative data for age and gender. From (Zilliox et al., 2011). Reproduced with permission.

References

    1. Abdul-Ghani MA, Tripathy D, DeFronzo RA, 2006. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29, 1130–1139. - PubMed
    1. Alberti KG, Zimmet PZ, 1998. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med 15, 539–553. - PubMed
    1. American Diabetes A, 2018. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care 41, S13–S27. - PubMed
    1. Annuzzi G, Rivellese A, Vaccaro O, Ferrante MR, Riccardi G, Mancini M, 1983. The relationship between blood glucose concentration and beat-to-beat variation in asymptomatic subjects. Acta Diabetol. Lat 20, 57–62. - PubMed
    1. Anon, 1996a. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45, 1289–1298. - PubMed

Publication types

MeSH terms